Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
30.66
-0.52 (-1.67%)
May 20, 2025, 4:00 PM - Market closed
Sanara MedTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 91.57 | 86.67 | 64.99 | 45.84 | 24.14 | 15.59 | Upgrade
|
| Revenue Growth (YoY) | 34.65% | 33.36% | 41.77% | 89.87% | 54.90% | 32.47% | Upgrade
|
| Cost of Revenue | 8.08 | 8.14 | 7.85 | 6.36 | 2.31 | 1.62 | Upgrade
|
| Gross Profit | 83.49 | 78.53 | 57.14 | 39.48 | 21.83 | 13.97 | Upgrade
|
| Selling, General & Admin | 79.49 | 74.25 | 56.99 | 46.09 | 28.26 | 18.67 | Upgrade
|
| Research & Development | 5.87 | 5.7 | 4.13 | 3.07 | 0.36 | 0.04 | Upgrade
|
| Operating Expenses | 89.8 | 84.36 | 64.8 | 51.53 | 29.21 | 19 | Upgrade
|
| Operating Income | -6.31 | -5.83 | -7.67 | -12.05 | -7.38 | -5.03 | Upgrade
|
| Interest Expense | -4.18 | -3.13 | -0.48 | - | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.02 | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | -0.23 | -0.09 | - | -0.38 | -0.62 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -10.7 | -9.03 | -8.14 | -12.43 | -7.99 | -5.03 | Upgrade
|
| Merger & Restructuring Charges | -1.35 | -1.35 | - | -0.19 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.25 | -1.04 | - | - | Upgrade
|
| Asset Writedown | -0.51 | -0.51 | - | - | - | - | Upgrade
|
| Other Unusual Items | 0.91 | 0.97 | 3.45 | -0.28 | - | 0.59 | Upgrade
|
| Pretax Income | -11.64 | -9.91 | -4.44 | -13.94 | -7.99 | -4.45 | Upgrade
|
| Income Tax Expense | - | - | - | -5.84 | - | - | Upgrade
|
| Earnings From Continuing Operations | -11.64 | -9.91 | -4.44 | -8.09 | -7.99 | -4.45 | Upgrade
|
| Minority Interest in Earnings | 0.21 | 0.25 | 0.14 | 0.15 | 0.07 | 0.09 | Upgrade
|
| Net Income | -11.43 | -9.66 | -4.3 | -7.94 | -7.92 | -4.36 | Upgrade
|
| Net Income to Common | -11.43 | -9.66 | -4.3 | -7.94 | -7.92 | -4.36 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 7 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 7 | 6 | Upgrade
|
| Shares Change (YoY) | 2.18% | 2.48% | 4.71% | 7.70% | 28.02% | 168.88% | Upgrade
|
| EPS (Basic) | -1.34 | -1.14 | -0.52 | -1.00 | -1.08 | -0.76 | Upgrade
|
| EPS (Diluted) | -1.34 | -1.14 | -0.52 | -1.00 | -1.08 | -0.76 | Upgrade
|
| Free Cash Flow | -2.29 | -0.23 | -3.51 | -5.7 | -4.99 | -4.58 | Upgrade
|
| Free Cash Flow Per Share | -0.27 | -0.03 | -0.42 | -0.72 | -0.68 | -0.80 | Upgrade
|
| Gross Margin | 91.17% | 90.61% | 87.92% | 86.13% | 90.43% | 89.63% | Upgrade
|
| Operating Margin | -6.90% | -6.73% | -11.79% | -26.27% | -30.55% | -32.30% | Upgrade
|
| Profit Margin | -12.48% | -11.15% | -6.62% | -17.32% | -32.81% | -27.95% | Upgrade
|
| Free Cash Flow Margin | -2.50% | -0.27% | -5.40% | -12.44% | -20.65% | -29.38% | Upgrade
|
| EBITDA | -1.88 | -1.42 | -3.99 | -9.67 | -6.78 | -4.74 | Upgrade
|
| EBITDA Margin | -2.05% | -1.63% | -6.14% | -21.10% | -28.08% | -30.43% | Upgrade
|
| D&A For EBITDA | 4.44 | 4.42 | 3.68 | 2.37 | 0.6 | 0.29 | Upgrade
|
| EBIT | -6.31 | -5.83 | -7.67 | -12.05 | -7.38 | -5.03 | Upgrade
|
| EBIT Margin | -6.90% | -6.73% | -11.79% | -26.27% | -30.55% | -32.30% | Upgrade
|
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.